Novozymes A/S

    Jurisdiction
    Denmark
    LEI
    529900T6WNZXD2R3JW38
    ISIN
    DK0060336014 (NZYM-B.CO)
    Sectors
    1. Basic Materials
    2. Chemicals - Specialty

    Scores

    InsiderPie Expert Score
    52 / 100
    Even with peer group:
    53 / 100
    Fair value (Benjamin Graham formula)
    €73.34 34.4% undervalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. Read full profile

    Fundamentals

    Net revenue
    €5.10B
    Gross margin
    54.8%
    EBIT
    €1.08B
    EBIT margin
    21.1%
    Net income
    €685.51M
    Net margin
    13.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €4.48B -12.2% €808.34M +17.9%
    €4.80B +7.2% €924.16M +14.3%
    €5.15B +7.4% €1.08B +16.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    DKK 4.20
    Ex date
    Payment date
    Dividend payout ratio
    65.6%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Earnings Calls

    Latest earnings call: May 3, 2024 (Q1 2024)

    Add to watchlist

    Notifications